International Biotechnology Trust PLC Intra Cellular Therapies, Inc. Transaction History

International Biotechnology Trust PLC

$295 Million
Q3 2023

A detailed history of International Biotechnology Trust PLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 317,856 shares of ITCI stock, worth $27.2 Million. This represents 5.62% of its overall portfolio holdings.

Number of Shares

317,856

Previous 176,856 79.73%

Holding current value

$27.2 Million

Previous $11.2 Million 47.86%

% of portfolio

5.62%

Previous 3.49%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$52.09 - $64.1 $7.34 Million - $9.04 Million	141,000 Added 79.73%	317,856 $16.6 Million
Q2 2023 Aug 08, 2023	SELL	$54.67 - $66.44 $4.43 Million - $5.38 Million	-81,000 Reduced 31.41%	176,856 $11.2 Million
Q1 2023 May 18, 2023	BUY	$43.8 - $56.99 $1.58 Million - $2.05 Million	36,000 Added 16.23%	257,856 $14 Million
Q3 2022 Nov 08, 2022	BUY	$42.7 - $59.99 $9.32 Million - $13.1 Million	218,253 Added 6057.54%	221,856 $10.3 Million
Q2 2022 Aug 16, 2022	SELL	$43.0 - $65.64 $2.04 Million - $3.11 Million	-47,353 Reduced 92.93%	3,603 $63.2 Million
Q1 2022 May 20, 2022	SELL	$38.74 - $62.09 $2.42 Million - $3.88 Million	-62,500 Reduced 55.09%	50,956 $3.12 Million
Q4 2021 Feb 15, 2022	BUY	$35.2 - $53.42 $1.2 Million - $1.82 Million	34,000 Added 42.79%	113,456 $5.92 Million
Q4 2020 Feb 19, 2021	BUY	$23.34 - $32.22 $1.28 Million - $1.76 Million	54,656 Added 220.39%	79,456 $2.53 Million
Q3 2020 Dec 01, 2020	BUY	$17.61 - $31.86 $31,698 - $57,348	1,800 Added 7.83%	24,800 $637,000
Q1 2020 May 18, 2020	BUY	$12.31 - $33.12 $283,130 - $761,759	23,000 New	23,000 $352,000

Others Institutions Holding ITCI

# of Institutions

377

Shares Held

84.7M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.08B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Account

International Biotechnology Trust PLC Intra Cellular Therapies, Inc. Transaction History